Kenai Therapeutics
Latest round
- Series A
Last raised
- Feb 2024
Total raised
- $85M
Investors
- 5
About Kenai Therapeutics
Based in California, US, and founded in 2022 by co-founders Dr. Howard Federoff and Dr. Jeffrey Kordower, Kenai Therapeutics, Inc., operates as a provider of neuron replacement cell therapies for neurological disorders using induced pluripotent stem cell (iPSC) technology. In February 2024, Kenai Therapeutics, Inc. The company provides a wide range of dopamine neuron replacement therapy products, including RNDP-001, an iPSC dopamine progenitor for Parkinson’s disease treatment; RNDP-002 for mild to severe rapid-progressing Parkinson’s disease; and RNDP-003 for young-onset Parkinson’s disease. Additionally, the firm offers preclinical and discovery programs using gene-modified iPSC technology.
Who invested in Kenai Therapeutics
5 investors across 2 rounds
See all investors in Kenai Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kenai Therapeutics
Who invested in Kenai Therapeutics?
Kenai Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kenai Therapeutics raised?
Kenai Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Kenai Therapeutics last raise money?
Kenai Therapeutics's most recent round on record is a Series A, in Feb 2024.
What does Kenai Therapeutics do?
Based in California, US, and founded in 2022 by co-founders Dr.
Where is Kenai Therapeutics headquartered?
Kenai Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Kenai Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kenai Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Kenai Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.